TP53 gene mutations in canine osteosarcoma

Veterinary Surgery

Volumn 37, Issue 5, 2008, Pages 454-460

  Kirpensteijn, Jolle ^a   Kik, Marja ^a   Teske, Erik ^a   Rutteman, Gerard R ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; TUMOR MARKER;

ANIMAL; ANIMAL DISEASE; ARTICLE; BONE TUMOR; CANCER STAGING; DISEASE FREE SURVIVAL; DOG; DOG DISEASE; FEMALE; GENETICS; KAPLAN MEIER METHOD; MALE; METABOLISM; METHODOLOGY; MORTALITY; MUTATION; OSTEOSARCOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

ALKALINE PHOSPHATASE; ANIMALS; BONE NEOPLASMS; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; FEMALE; GENES, P53; KAPLAN-MEIERS ESTIMATE; MALE; MUTATION; NEOPLASM STAGING; OSTEOSARCOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; CANIS FAMILIARIS;

EID: 47349096228     PISSN: 01613499     EISSN: 1532950X     Source Type: Journal    
DOI: 10.1111/j.1532-950X.2008.00407.x     Document Type: Article

References (48)

1. Misdorp W, Hart AAM : Some prognostic and epidemiologic factors in canine osteosarcoma. J Natl Cancer Inst 62 : 537 545, 1979
2. Goorin AM, Abelson HT, Frei E, III. : Osteosarcoma: fifteen years later. N Engl J Med 313 : 1637 1643, 1985
3. O'Brien MG, Straw RC, Withrow SJ : Recent advances in the treatment of canine appendicular osteosarcoma. Compend Contin Educ Pract Vet 15 : 939 947, 1993
4. Meyers PA, Gorlick R : Osteosarcoma. Pediatr Clin North Am 44 : 973, 1997
5. Greenblatt MS, Bennett WP, Hollstein M, et al : Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54 : 4855 4878, 1994
6. Chu LL, Rutteman GR, Kong JMC, et al : Genomic organization of the canine p53 gene and its mutational status in canine mammary neoplasia. Breast Cancer Res Treat 50 : 11 25, 1998
7. Mayr B, Dressler A, Reifinger M, et al : Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs. Am J Vet Res 59 : 69 78, 1998
8. van Leeuwen IS, Hellmén E, Cornelisse CJ, et al : p53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog. Anticancer Res 16 : 3737 3744, 1996
9. Devilee P, van Leeuwen IS, Voesten A, et al : The canine p53 gene is subject to somatic changes in thyroid carcinoma. Anticancer Res 14 : 2039 2046, 1994
10. Veldhoen N, Stewart J, Brown R, et al : Mutations of the p53 gene in canine lymphoma and evidence for germline p53 mutations in the dog. Oncogene 16 : 249 255, 1997
11. Tierney LA, Hahn FF, Lechner JF : p53, erb-2 and k-ras gene alterations are rare in spontaneous and plutonium-239-induced canine lung neoplasia. Radiat Res 145 : 181 187, 1996
12. Setoguchi A, Sakai T, Okuda M, et al : Aberrations of the p53 tumor suppressor gene in various tumors in dogs. Am J Vet Res 62 : 433 439, 2001
13. Miller CW, Aslo A, Won A, et al : Alterations of the p53, Rb and MDM2 genes in osteosarcoma. J Cancer Res Clin Onc 122 : 559 565, 1996
14. Radig K, Schneider-Stock R, Oda Y, et al : Mutation spectrum of p53 gene in highly malignant human osteosarcoma. Gen Diagn Pathol 142 : 25 32, 1996
15. Toguchida J, Yamaguchi T, Ritchie B, et al : Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 52 : 6194 6199, 1992
16. Overholtzer M, Rao PH, Favis R, et al : The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability. Proc Natl Acad Sci USA 100 : 11547 11552, 2003
17. Mendoza S, Konishi T, Dernell WS, et al : Status of the p53, Rb and MDM2 genes in canine osteosarcoma. Anticancer Res 18 : 4449 4454, 1998
18. Johnson AS, Couto CG, Weghorst CM : Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog. Carcinogenesis 19 : 213 217, 1998
19. Mayr B, Reifinger M, Loupal G : Polymorphisms in feline tumour suppressor gene p53. Mutations in an osteosarcoma and a mammary carcinoma. Vet J 155 : 103 106, 1998
20. van Leeuwen IS, Cornelisse CJ, Misdorp W, et al : p53 mutations in osteosarcomas in the dog. Cancer Lett 111 : 173 178, 1996
21. Abudu A, Mangham DC, Reynolds GM, et al : Overexpression of p53 protein in primary Ewing's sarcoma of bone; relationship to tumor stage, response and prognosis. Br J Cancer 79 : 1185 1189, 1999
22. Goto A, Kanda H, Ishikawa Y, et al : Association of loss of heterozygosity at the p53 locus with chemoresistance in osteosarcomas. Jpn J Cancer Res 89 : 539 547, 1998
23. Kirpensteijn J, Kik M, Rutteman GR, et al : The prognostic significance of a new histologic grading system for canine osteosarcoma. Vet Pathol 39 : 240 246, 2002
24. Matthews DE, Farewell VT : Using and Understanding Medical Statistics. Basel, S. Karger AG, 1996
25. Hansen MF : Molecular genetic considerations in osteosarcoma. Clin Orthop 270 : 237 246, 1991
26. Sagartz JE, Bodley WL, Gamblin RM, et al : p53 tumor suppressor protein overexpression in osteogenic tumors of dogs. Vet Pathol 33 : 213 221, 1996
27. Hung J, Anderson R : p53: functions, mutations and sarcomas. Acta Orthop Scand 273 : 68 73, 1997
28. Loukopoulos P, Thornton JR, Robinson WF : Clinical and pathologic relevance of p53 index in canine osseous tumors. Vet Pathol 40 : 237 248, 2003
29. Pellin A, Boix-Ferrero J, Carpio D, et al : Molecular alterations of the RB1, TP53, and MDM2 genes in primary and xenografted human osteosarcomas. Diagn Mol Pathol 6 : 333 341, 1997
30. Ueda Y, Dockhorn-Dworniczak B, Blasius S, et al : Analysis of mutant p53 protein in osteosarcomas and other malignant and benign lesions of bone. J Cancer Res Clin Onc 119 : 172 178, 1993
31. Mulligan LM, Mathlashewski GJ, Scrable HJ, et al : Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci USA 87 : 5863 5867, 1990
32. Pompetti F, Rizzo P, Simon RM, et al : Oncogene alterations in primary, recurrent, and metastatic human bone tumors. J Cell Biochem 63 : 37 50, 1996
33. Smith-Sorensen B, Gebhardt MC, Loen P, et al : Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE). Hum Mut 2 : 274 285, 1995
34. Castresana JS, Rubio MP, Gomez L, et al : Detection of TP53 gene mutations in human sarcomas. Eur J Cancer 31A : 735 738, 1995
35. Wadayama B, Toguchida J, Yamaguchi T, et al : p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 68 : 1134 1139, 1993
36. Masuda H, Miller C, Koeffler HP, et al : Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci USA 84 : 7716 7719, 1987
37. Lonardo F, Ueda T, Huvos AG, et al : p53 and MDM2 alterations in osteosarcomas. Cancer 79 : 1541 1547, 1997
38. Withrow SJ, Powers BE, Straw RC, et al : Comparative aspects of osteosarcoma. Dog versus man. Clin Orthop 270 : 159 168, 1991
39. MacEwen EG : Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev 9 : 125 136, 1990
40. Hahn KA, Bravo L, Adams WH, et al : Naturally occurring tumors as comparative models for cancer therapy research. In Vivo 8 : 133 144, 1994
41. Komuru H, Hayashi Y, Kawamura M, et al : Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res 53 : 5284 5288, 1993
42. Iavarone A, Matthay KK, Steinkirchner TM, et al : Germ-line and somatic p53 mutations in multifocal osteogenic sarcoma. Proc Natl Acad Sci USA 89 : 4207 4209, 1992
43. Yokoyama R, Schneider-Stock R, Radig K, et al : Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors. Pathol Res Pract 194 : 615 621, 1998
44. McIntyre JF, Smith-Sorensen B, Friend SH, et al : Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol 12 : 925 930, 1994
45. Hasegawa T, Hirose T, Seki K, et al : Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas. Cancer Detect Prevent 21 : 280 287, 1997
46. Oliveira P, Nogueira M, Pinto A, et al : Analysis of p53 expression in osteosarcoma of the jaw: correlation with clinicopathologic and DNA ploidy findings. Hum Pathol 28 : 1361 1365, 1997
47. Wunder JS, Gokgoz N, Parkes R, et al : TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study. J Clin Oncol 23 : 1483 1490, 2005
48. Pakos EE, Kyzas PA, Ioannidis JP : Prognostic significance of TP53 tumor suppressor gene expression and mutations in human osteosarcoma: a meta-analysis. Clin Cancer Res 10 : 6208 6214, 2004